Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) Return on Assets (2016 - 2025)

Ironwood Pharmaceuticals' Return on Assets history spans 15 years, with the latest figure at 0.14% for Q4 2025.

  • For Q4 2025, Return on Assets fell 14.0% year-over-year to 0.14%; the TTM value through Dec 2025 reached 0.14%, down 14.0%, while the annual FY2025 figure was 0.31%, 31.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.14% at Ironwood Pharmaceuticals, down from 0.08% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.59% in Q2 2021 and bottomed at 2.88% in Q1 2024.
  • The 5-year median for Return on Assets is 0.04% (2024), against an average of 0.31%.
  • The largest annual shift saw Return on Assets tumbled -309bps in 2024 before it surged 278bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.48% in 2021, then crashed by -53bps to 0.22% in 2022, then crashed by -1224bps to 2.53% in 2023, then soared by 100bps to 0.0% in 2024, then plummeted by -5648bps to 0.14% in 2025.
  • Per Business Quant, the three most recent readings for IRWD's Return on Assets are 0.14% (Q4 2025), 0.08% (Q3 2025), and 0.02% (Q2 2025).